This company, established in the early 1980s in South Asia, has a strong focus on innovative drug delivery systems (NDDS). With over three decades of experience, it boasts multiple globally patented technologies and has grown into a significant player in the pharmaceutical sector. The company's portfolio includes a diverse range of products in therapeutic areas like pain management, gynecology, and critical care. It also develops nutraceuticals and nutritional supplements. The company offers a variety of dosage forms, including oral, injectable, and potentially liquid forms. They manufacture products in state-of-the-art facilities, adhering to stringent GMP standards. These facilities hold approvals from international regulatory agencies, including WHO, PIC/S, and ANVISA, and are currently pursuing EU and USFDA certifications. The company's footprint extends across key regions, including Asia, Africa, Latin America, and the CIS. This global reach is further strengthened by a dedicated regulatory, operational, marketing, and business development teams. The company actively engages in licensing agreements with multinational and regional players, demonstrating its commitment to innovation and partnership.

This company, based in South Asia, is a rapidly growing pharmaceutical manufacturer with a focus on both domestic and international markets. They specialize in a wide range of therapeutic areas, including antiretrovirals, antimalarials, cardiovascular, dermatology, and ophthalmology. Their product portfolio includes both prescription and over-the-counter medications, with a growing presence in nature-based remedies. The company has a strong track record of quality and service, evidenced by their approval to supply medicines to government institutions and organizations like MSF and PSF. Their manufacturing capabilities include various dosage forms, and they hold multiple GMP certifications, including EU and US approvals. With a history spanning over two decades, this company continues to expand its global reach, particularly in key regions like Europe and North America.